TY - JOUR
T1 - Racial and Ethnic Differences in Genomic Profiling of Early Onset Colorectal Cancer
AU - Hein, David M.
AU - Deng, Weiye
AU - Bleile, Mary Lena
AU - Kazmi, Syed Ali
AU - Rhead, Brooke
AU - De La Vega, Francisco M.
AU - Jones, Amy L.
AU - Kainthla, Radhika
AU - Jiang, Wen
AU - Cantarel, Brandi
AU - Sanford, Nina N.
N1 - Publisher Copyright:
© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.
PY - 2022/5/9
Y1 - 2022/5/9
N2 - The incidence and mortality of early onset colorectal cancer (EOCRC) is rising; outcomes appear to differ by race and ethnicity. We aimed to assess differences in mutational landscape and gene expression of EOCRC by racial and ethnic groups (non-Hispanic Asian, non-Hispanic Black, non-Hispanic White, White Hispanic) using data from the American Association for Cancer Research Project GENIE (10.2) and University of Texas Southwestern, the latter enriched in Hispanic patients. All statistical tests were 2-sided. Of 1752 EOCRC patients, non-Hispanic Black patients had higher rates of KRAS mutations (60.9%; P = .001, q = 0.015), and non-Hispanic White and non-Hispanic Black patients had higher rates of APC mutations (77.1% and 76.6% among non-Hispanic White and non-Hispanic Black patients, respectively; P = .001, q = 0.015) via the Fisher exact test with Benjamini-Hochberg correction. Using R packages DESeq2 and clusterProfiler, we found that White Hispanic patients had increased expression of genes involved in oxidative phosphorylation (P < .001, q = 0.025). Genomic profiling has the potential to identify novel diagnostics and influence individualized treatment options to address the currently limited prognosis of EOCRC.
AB - The incidence and mortality of early onset colorectal cancer (EOCRC) is rising; outcomes appear to differ by race and ethnicity. We aimed to assess differences in mutational landscape and gene expression of EOCRC by racial and ethnic groups (non-Hispanic Asian, non-Hispanic Black, non-Hispanic White, White Hispanic) using data from the American Association for Cancer Research Project GENIE (10.2) and University of Texas Southwestern, the latter enriched in Hispanic patients. All statistical tests were 2-sided. Of 1752 EOCRC patients, non-Hispanic Black patients had higher rates of KRAS mutations (60.9%; P = .001, q = 0.015), and non-Hispanic White and non-Hispanic Black patients had higher rates of APC mutations (77.1% and 76.6% among non-Hispanic White and non-Hispanic Black patients, respectively; P = .001, q = 0.015) via the Fisher exact test with Benjamini-Hochberg correction. Using R packages DESeq2 and clusterProfiler, we found that White Hispanic patients had increased expression of genes involved in oxidative phosphorylation (P < .001, q = 0.025). Genomic profiling has the potential to identify novel diagnostics and influence individualized treatment options to address the currently limited prognosis of EOCRC.
UR - http://www.scopus.com/inward/record.url?scp=85130001518&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85130001518&partnerID=8YFLogxK
U2 - 10.1093/jnci/djac014
DO - 10.1093/jnci/djac014
M3 - Article
C2 - 35134211
AN - SCOPUS:85130001518
SN - 0027-8874
VL - 114
SP - 775
EP - 778
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 5
ER -